News|Articles|November 14, 2023

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.

Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Subscribe Now!

Related Content

The Clean Bite: Real Talk About Infection Control—Single-Use vs Reusable Dental Supplies: What Is the Difference and Why It Matters

BySherrie Busby, EDDA, CDSO, CDIPC

November 6th 2025

3d rendered HIV Virus in bloodstream (Adobe Stock 200344697 by RAJCREATIONZS)

Latest CME

Video

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

Newsletter

Related Content

The Clean Bite: Real Talk About Infection Control—Single-Use vs Reusable Dental Supplies: What Is the Difference and Why It Matters

Breaking the Silence: How to Talk About HIV and PrEP Without Fear

What Are the Infection Prevention Risks in the Hospital Tray Line?

Editor's Letter: Tim and Monica's Story About Sepsis, Survival, and the Strength to Keep Going

Multidrug-Resistant Infections Necessitate Bacteriophage Treatment: Can We Get There in Time?

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Trending on Infection Control Today

The Clean Bite: Real Talk About Infection Control—Single-Use vs Reusable Dental Supplies: What Is the Difference and Why It Matters

Breaking the Silence: How to Talk About HIV and PrEP Without Fear